|
1
|
Webb PM and Jordan SJ: Epidemiology of
epithelial ovarian cancer. Best Pract Res Clin Obstet Gynaecol.
41:3–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mahdian-Shakib A, Dorostkar R, Tat M,
Hashemzadeh MS and Saidi N: Differential role of microRNAs in
prognosis, diagnosis, and therapy of ovarian cancer. Biomed
Pharmacother. 84:592–600. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yu G, Jia Z and Dou Z: miR-24-3p regulates
bladder cancer cell proliferation, migration, invasion and
autophagy by targeting DEDD. Oncol Rep. 37:1123–1131. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma Q, Peng Z, Wang L, Li Y, Wang K, Zheng
J, Liang Z and Liu T: miR-19a correlates with poor prognosis of
clear cell renal cell carcinoma patients via promoting cell
proliferation and suppressing PTEN/SMAD4 expression. Int J Oncol.
49:2589–2599. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fu X, Li Y, Alvero A, Li J, Wu Q, Xiao Q,
Peng Y, Hu Y, Li X, Yan W, et al: MicroRNA-222-3p/GNAI2/AKT axis
inhibits epithelial ovarian cancer cell growth and associates with
good overall survival. Oncotarget. 7:80633–80654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jeong JY, Kang H, Kim TH, Kim G, Heo JH,
Kwon AY, Kim S, Jung SG and An HJ: MicroRNA-136 inhibits cancer
stem cell activity and enhances the anti-tumor effect of paclitaxel
against chemoresistant ovarian cancer cells by targeting Notch3.
Cancer Lett. 386:168–178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tian S, Zhang M, Chen X, Liu Y and Lou G:
MicroRNA-595 sensitizes ovarian cancer cells to cisplatin by
targeting ABCB1. Oncotarget. 7:87091–87099. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou F, Chen J and Wang H: MicroRNA-298
inhibits malignant phenotypes of epithelial ovarian cancer by
regulating the expression of EZH2. Oncol Lett. 12:3926–3932. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hu K and Liang M: Upregulated microRNA-224
promotes ovarian cancer cell proliferation by targeting KLLN. In
Vitro Cell Dev Biol Anim. 53:149–156. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liang T, Li L, Cheng Y, Ren C and Zhang G:
MicroRNA-194 promotes the growth, migration, and invasion of
ovarian carcinoma cells by targeting protein tyrosine phosphatase
nonreceptor type 12. Onco Targets Ther. 9:4307–4315. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu AH, Huang YL, Zhang LZ, Tian G, Liao QZ
and Chen SL: MiR-572 prompted cell proliferation of human ovarian
cancer cells by suppressing PPP2R2C expression. Biomed
Pharmacother. 77:92–97. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45(D1): D362–D368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marko TA, Shamsan GA, Edwards EN, Hazelton
PE, Rathe SK, Cornax I, Overn PR, Varshney J, Diessner BJ,
Moriarity BS, et al: Slit-Robo GTPase-activating protein 2 as a
metastasis suppressor in osteosarcoma. Sci Rep. 6:390592016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ito N, Sakai A, Miyake N, Maruyama M,
Iwasaki H, Miyake K, Okada T, Sakamoto A and Suzuki H: miR-15b
mediates oxaliplatin-induced chronic neuropathic pain through BACE1
downregulation. Br J Pharmacol. 174:386–395. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu Y, Qiu Y, Yagüe E, Ji W, Liu J and
Zhang J: miRNA-205 targets VEGFA and FGF2 and regulates resistance
to chemotherapeutics in breast cancer. Cell Death Dis. 7:e22912016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cañueto J, Cardeñoso-Álvarez E,
García-Hernández JL, Galindo-Villardón P, Vicente-Galindo P,
Vicente-Villardón JL, Alonso-López D, De Las Rivas J, Valero J,
Moyano-Sanz E, et al: MicroRNA (miR)-203 and miR-205 expression
patterns identify subgroups of prognosis in cutaneous squamous cell
carcinoma. Br J Dermatol. 177:168–178. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Osipov ID, Zaporozhchenko IA, Bondar AA,
Zaripov MM, Voytsitskiy VE, Vlassov VV, Laktionov PP and Morozkin
ES: Cell-free miRNA-141 and miRNA-205 as prostate cancer
biomarkers. Adv Exp Med Biol. 924:9–12. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pan F, Mao H, Bu F, Tong X, Li J, Zhang S,
Liu X, Wang L, Wu L, Chen R, et al: Sp1-mediated transcriptional
activation of miR-205 promotes radioresistance in esophageal
squamous cell carcinoma. Oncotarget. 8:5735–5752. 2017.PubMed/NCBI
|
|
20
|
Torres A, Kozak J, Korolczuk A, Rycak D,
Wdowiak P, Maciejewski R and Torres K: Locked nucleic
acid-inhibitor of miR-205 decreases endometrial cancer cells
proliferation in vitro and in vivo. Oncotarget. 7:73651–73663.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X, Yu M, Zhao K, He M, Ge W, Sun Y,
Wang Y, Sun H and Hu Y: Upregulation of MiR-205 under hypoxia
promotes epithelial-mesenchymal transition by targeting ASPP2. Cell
Death Dis. 7:e25172016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Iorio MV, Visone R, Di Leva G, Donati V,
Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, et
al: MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Niu K, Shen W, Zhang Y, Zhao Y and Lu Y:
MiR-205 promotes motility of ovarian cancer cells via targeting
ZEB1. Gene. 574:330–336. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li J, Li L, Li Z, Gong G, Chen P, Liu H,
Wang J, Liu Y and Wu X: The role of miR-205 in the VEGF-mediated
promotion of human ovarian cancer cell invasion. Gynecol Oncol.
137:125–133. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li J, Hu K, Gong G, Zhu D, Wang Y, Liu H
and Wu X: Upregulation of MiR-205 transcriptionally suppresses
SMAD4 and PTEN and contributes to human ovarian cancer progression.
Sci Rep. 7:413302017. View Article : Google Scholar : PubMed/NCBI
|
